PMC:7102662 / 2105-19612
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 2416-2423 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
T2 | 12284-12291 | https://glytoucan.org/Structures/Glycans/G15021LG | denotes | glucose |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 982-992 | Body_part | denotes | troponin I | http://purl.org/sig/ont/fma/fma62340 |
T4 | 982-990 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T5 | 1489-1504 | Body_part | denotes | coronary artery | http://purl.org/sig/ont/fma/fma49893 |
T6 | 1680-1685 | Body_part | denotes | Heart | http://purl.org/sig/ont/fma/fma7088 |
T7 | 1871-1876 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T8 | 1990-1995 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T9 | 2406-2411 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T10 | 2416-2423 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T11 | 2928-2945 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T12 | 4066-4074 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T13 | 4081-4086 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T14 | 4258-4261 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T15 | 4519-4536 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T16 | 4575-4584 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T17 | 4770-4775 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T18 | 4891-4896 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T19 | 4901-4906 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T20 | 4967-4976 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T21 | 5155-5159 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T22 | 5293-5301 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T23 | 5448-5457 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T24 | 5899-5904 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T25 | 6236-6245 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T26 | 8503-8508 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T27 | 9261-9271 | Body_part | denotes | troponin I | http://purl.org/sig/ont/fma/fma62340 |
T28 | 9261-9269 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T29 | 10060-10068 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T30 | 10119-10127 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T31 | 10310-10319 | Body_part | denotes | troponins | http://purl.org/sig/ont/fma/fma62338 |
T32 | 10734-10750 | Body_part | denotes | ribonucleic acid | http://purl.org/sig/ont/fma/fma67095 |
T33 | 10794-10799 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T34 | 11188-11193 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T35 | 11228-11233 | Body_part | denotes | Heart | http://purl.org/sig/ont/fma/fma7088 |
T36 | 12195-12200 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T37 | 12284-12291 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T38 | 12391-12408 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T39 | 14095-14103 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T40 | 14504-14513 | Body_part | denotes | troponins | http://purl.org/sig/ont/fma/fma62338 |
T41 | 15269-15276 | Body_part | denotes | tissues | http://purl.org/sig/ont/fma/fma9637 |
T42 | 15291-15305 | Body_part | denotes | cardiomyocytes | http://purl.org/sig/ont/fma/fma14067 |
T43 | 15368-15373 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1489-1504 | Body_part | denotes | coronary artery | http://purl.obolibrary.org/obo/UBERON_0001621 |
T2 | 1498-1504 | Body_part | denotes | artery | http://purl.obolibrary.org/obo/UBERON_0001637 |
T3 | 1680-1685 | Body_part | denotes | Heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T4 | 1871-1876 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T5 | 1990-1995 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T6 | 2928-2945 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
T7 | 4081-4086 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T8 | 4519-4536 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
T9 | 4891-4896 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T10 | 5155-5159 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T11 | 5348-5354 | Body_part | denotes | organs | http://purl.obolibrary.org/obo/UBERON_0000062 |
T12 | 5899-5904 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T13 | 8503-8508 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T14 | 10794-10799 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T15 | 11188-11193 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T16 | 11228-11233 | Body_part | denotes | Heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T17 | 12391-12408 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T21 | 72-119 | Disease | denotes | Severe Acute Respiratory Syndrome-Coronavirus-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T22 | 72-105 | Disease | denotes | Severe Acute Respiratory Syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T23 | 121-129 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T24 | 468-492 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T25 | 494-504 | Disease | denotes | COVID-2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T26 | 631-640 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T27 | 855-879 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T28 | 927-933 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T29 | 1181-1187 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T30 | 1198-1210 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T31 | 1423-1435 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T32 | 1489-1512 | Disease | denotes | coronary artery disease | http://purl.obolibrary.org/obo/MONDO_0005010 |
T33 | 1498-1512 | Disease | denotes | artery disease | http://purl.obolibrary.org/obo/MONDO_0000473 |
T34 | 1680-1693 | Disease | denotes | Heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T35 | 1871-1884 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T36 | 1919-1935 | Disease | denotes | systemic disease | http://purl.obolibrary.org/obo/MONDO_0015938 |
T37 | 1990-2003 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T38 | 2004-2014 | Disease | denotes | Arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T39 | 2239-2263 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T40 | 2326-2359 | Disease | denotes | Severe Acute Respiratory Syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T41 | 2490-2496 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T42 | 2679-2703 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T43 | 2787-2822 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T44 | 2793-2822 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T45 | 2836-2845 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T46 | 2889-2897 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T47 | 2928-2955 | Disease | denotes | respiratory tract infection | http://purl.obolibrary.org/obo/MONDO_0024355 |
T48 | 2946-2955 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T49 | 2970-2998 | Disease | denotes | cardiovascular disease (CVD) | http://purl.obolibrary.org/obo/MONDO_0004995 |
T50 | 3044-3052 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T51 | 3063-3071 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T52 | 3250-3258 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T53 | 3559-3567 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T54 | 3630-3634 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T55 | 3906-3914 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T56 | 3939-3947 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T57 | 4027-4037 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T58 | 4041-4062 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T59 | 4081-4094 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T60 | 4150-4154 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T61 | 4216-4224 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T62 | 4347-4357 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T63 | 4472-4476 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T64 | 4499-4507 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T65 | 4563-4571 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T66 | 4701-4709 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T67 | 4738-4744 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T68 | 4746-4754 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T69 | 5051-5059 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T70 | 5160-5166 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T71 | 5187-5199 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T72 | 5222-5230 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T73 | 5329-5335 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T74 | 5366-5384 | Disease | denotes | multiorgan failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
T75 | 5491-5499 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T76 | 5613-5622 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T77 | 5765-5771 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T78 | 5796-5815 | Disease | denotes | coronary thrombosis | http://purl.obolibrary.org/obo/MONDO_0006716 |
T79 | 5805-5815 | Disease | denotes | thrombosis | http://purl.obolibrary.org/obo/MONDO_0000831 |
T80 | 5826-5838 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T81 | 5954-5981 | Disease | denotes | acute myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0004781 |
T82 | 5960-5981 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T83 | 6024-6036 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T84 | 6186-6194 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T85 | 6357-6368 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T86 | 6455-6466 | Disease | denotes | hypokalemia | http://purl.obolibrary.org/obo/MONDO_0003019 |
T87 | 6470-6478 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T88 | 6502-6510 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T89 | 6560-6571 | Disease | denotes | Hypokalemia | http://purl.obolibrary.org/obo/MONDO_0003019 |
T90 | 6754-6762 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T91 | 6982-6991 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T92 | 7074-7082 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T93 | 7128-7136 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T94 | 7145-7168 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T95 | 7173-7185 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T96 | 7231-7239 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T97 | 7244-7256 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T98 | 7344-7367 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T99 | 7427-7435 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T100 | 7444-7467 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T101 | 7472-7484 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T102 | 7803-7811 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T103 | 7960-7972 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T104 | 7974-7982 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T105 | 8462-8470 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T106 | 8492-8516 | Disease | denotes | congestive heart failure | http://purl.obolibrary.org/obo/MONDO_0005009 |
T107 | 8503-8516 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T108 | 8884-8892 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T109 | 8918-8924 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T110 | 8942-8948 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T111 | 8999-9007 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T112 | 9090-9096 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T113 | 9407-9413 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T114 | 9628-9634 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T115 | 9849-9855 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T116 | 9943-9951 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T117 | 10283-10289 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T118 | 10337-10345 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T119 | 10460-10466 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T120 | 10474-10491 | Disease | denotes | viral myocarditis | http://purl.obolibrary.org/obo/MONDO_0023161 |
T121 | 10480-10491 | Disease | denotes | myocarditis | http://purl.obolibrary.org/obo/MONDO_0004496 |
T122 | 10518-10530 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T123 | 10665-10669 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T124 | 10689-10693 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T125 | 10850-10856 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T126 | 10911-10953 | Disease | denotes | ST-segment elevation myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0041656 |
T127 | 10932-10953 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T128 | 10957-10965 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T129 | 11188-11201 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T130 | 11205-11213 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T131 | 11228-11241 | Disease | denotes | Heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T132 | 11408-11419 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T133 | 11442-11450 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T134 | 11530-11538 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T135 | 11567-11577 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T136 | 11723-11733 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T137 | 11794-11802 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T138 | 12012-12016 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T139 | 12028-12036 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T140 | 12079-12087 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T141 | 12150-12154 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T142 | 12391-12419 | Disease | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/MONDO_0024355 |
T143 | 12499-12507 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T144 | 12723-12731 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T145 | 12832-12840 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T146 | 13090-13098 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T147 | 13393-13401 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T148 | 13552-13560 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T149 | 13941-13949 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T150 | 14371-14380 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T151 | 14700-14708 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T152 | 14993-15001 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T153 | 15019-15061 | Disease | denotes | ST-segment elevation myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0041656 |
T154 | 15040-15061 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T155 | 15172-15175 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T156 | 15196-15204 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T157 | 15318-15326 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T158 | 15427-15435 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T159 | 15532-15535 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T160 | 15820-15823 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T161 | 15866-15874 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T162 | 16028-16043 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T163 | 16034-16043 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T164 | 16862-16870 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T165 | 16949-16957 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T166 | 17149-17157 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T167 | 17241-17249 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 134-137 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T7 | 371-376 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T8 | 415-416 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 591-592 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T10 | 641-644 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T11 | 763-775 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
T12 | 1498-1504 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | artery |
T13 | 1498-1504 | http://www.ebi.ac.uk/efo/EFO_0000814 | denotes | artery |
T14 | 1680-1685 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | Heart |
T15 | 1680-1685 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | Heart |
T16 | 1680-1685 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | Heart |
T17 | 1680-1685 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | Heart |
T18 | 1717-1719 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
T19 | 1871-1876 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T20 | 1871-1876 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T21 | 1871-1876 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T22 | 1871-1876 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T23 | 1917-1918 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 1990-1995 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T25 | 1990-1995 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T26 | 1990-1995 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T27 | 1990-1995 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T28 | 2299-2300 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T29 | 2500-2501 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T30 | 2639-2642 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T31 | 3699-3700 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T32 | 4081-4086 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T33 | 4081-4086 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T34 | 4081-4086 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T35 | 4081-4086 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T36 | 4240-4241 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T37 | 4341-4346 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T38 | 4575-4584 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T39 | 4764-4775 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T40 | 4830-4831 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T41 | 4832-4840 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T42 | 4891-4896 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T43 | 4891-4896 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T44 | 4891-4896 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T45 | 4891-4896 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T46 | 4901-4906 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T47 | 4967-4976 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T48 | 5103-5112 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T49 | 5155-5159 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T50 | 5155-5159 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T51 | 5348-5354 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organs |
T52 | 5899-5904 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T53 | 5899-5904 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T54 | 6236-6245 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T55 | 6993-6994 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T56 | 7505-7508 | http://purl.obolibrary.org/obo/CLO_0001562 | denotes | a 2 |
T57 | 7505-7508 | http://purl.obolibrary.org/obo/CLO_0001563 | denotes | a 2 |
T58 | 7667-7668 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T59 | 8288-8293 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2]. A |
T60 | 8381-8382 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T61 | 8503-8508 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T62 | 8503-8508 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T63 | 8503-8508 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T64 | 8503-8508 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T65 | 9414-9417 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T66 | 9699-9700 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T67 | 9856-9859 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T68 | 9890-9891 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T69 | 10128-10131 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T70 | 10395-10398 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T71 | 10608-10609 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T72 | 10704-10706 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T73 | 10767-10769 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T74 | 10788-10793 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T75 | 10794-10799 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T76 | 10794-10799 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T77 | 10794-10799 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T78 | 10794-10799 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T79 | 10864-10869 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T80 | 10880-10883 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T81 | 10911-10913 | http://purl.obolibrary.org/obo/CLO_0009141 | denotes | ST |
T82 | 10911-10913 | http://purl.obolibrary.org/obo/CLO_0050980 | denotes | ST |
T83 | 11188-11193 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T84 | 11188-11193 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T85 | 11188-11193 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T86 | 11188-11193 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T87 | 11228-11233 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | Heart |
T88 | 11228-11233 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | Heart |
T89 | 11228-11233 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | Heart |
T90 | 11228-11233 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | Heart |
T91 | 11258-11260 | http://purl.obolibrary.org/obo/CLO_0001407 | denotes | 52 |
T92 | 11452-11453 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T93 | 11803-11806 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T94 | 11820-11821 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T95 | 12861-12862 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T96 | 13187-13197 | http://purl.obolibrary.org/obo/CLO_0002807 | denotes | in donning |
T97 | 14075-14080 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T98 | 14417-14420 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T99 | 14530-14538 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
T100 | 14751-14754 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T101 | 14767-14768 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T102 | 15019-15021 | http://purl.obolibrary.org/obo/CLO_0009141 | denotes | ST |
T103 | 15019-15021 | http://purl.obolibrary.org/obo/CLO_0050980 | denotes | ST |
T104 | 15072-15075 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T105 | 15081-15082 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T106 | 15291-15305 | http://purl.obolibrary.org/obo/CL_0000746 | denotes | cardiomyocytes |
T107 | 15362-15373 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T108 | 15384-15385 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T109 | 16917-16918 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 1223-1229 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T2 | 2406-2411 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T3 | 2416-2423 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T5 | 4262-4266 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
T6 | 4303-4307 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
T7 | 4790-4801 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T8 | 5702-5708 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T9 | 6115-6130 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
T10 | 6115-6124 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T11 | 6125-6130 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 6132-6147 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T13 | 6524-6535 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T14 | 6536-6547 | Chemical | denotes | aldosterone | http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834 |
T16 | 10734-10750 | Chemical | denotes | ribonucleic acid | http://purl.obolibrary.org/obo/CHEBI_33697 |
T17 | 10746-10750 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T18 | 10911-10913 | Chemical | denotes | ST | http://purl.obolibrary.org/obo/CHEBI_141393 |
T19 | 12195-12200 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T20 | 12284-12291 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234|http://purl.obolibrary.org/obo/CHEBI_4167 |
T22 | 14530-14538 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
T23 | 15019-15021 | Chemical | denotes | ST | http://purl.obolibrary.org/obo/CHEBI_141393 |
T24 | 15115-15129 | Chemical | denotes | ACE inhibitors | http://purl.obolibrary.org/obo/CHEBI_35457 |
T25 | 15119-15129 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T26 | 15131-15135 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T27 | 15141-15152 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T28 | 15527-15531 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T29 | 15815-15819 | Chemical | denotes | ACEi | http://purl.obolibrary.org/obo/CHEBI_35457 |
T30 | 16083-16088 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T31 | 16132-16137 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T32 | 16222-16233 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T33 | 16234-16252 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T34 | 16257-16269 | Chemical | denotes | azathioprine | http://purl.obolibrary.org/obo/CHEBI_2948 |
T35 | 16370-16375 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T36 | 16528-16539 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T37 | 16540-16558 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T38 | 16713-16717 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T6 | 1085-1111 | Phenotype | denotes | cardiovascular abnormality | http://purl.obolibrary.org/obo/HP_0001626 |
T7 | 1513-1550 | Phenotype | denotes | Left ventricular systolic dysfunction | http://purl.obolibrary.org/obo/HP_0025169 |
T8 | 1642-1679 | Phenotype | denotes | left ventricular systolic dysfunction | http://purl.obolibrary.org/obo/HP_0025169 |
T9 | 1680-1693 | Phenotype | denotes | Heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T10 | 1871-1884 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T11 | 1990-2003 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T12 | 2004-2014 | Phenotype | denotes | Arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T13 | 2793-2813 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T14 | 2836-2845 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T15 | 2928-2955 | Phenotype | denotes | respiratory tract infection | http://purl.obolibrary.org/obo/HP_0011947 |
T16 | 2970-2992 | Phenotype | denotes | cardiovascular disease | http://purl.obolibrary.org/obo/HP_0001626 |
T17 | 4027-4037 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T18 | 4041-4062 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T19 | 4081-4094 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T20 | 5293-5307 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
T21 | 5636-5643 | Phenotype | denotes | hypoxia | http://purl.obolibrary.org/obo/HP_0012418 |
T22 | 5660-5679 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
T23 | 5960-5981 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T24 | 6357-6368 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T25 | 6455-6466 | Phenotype | denotes | hypokalemia | http://purl.obolibrary.org/obo/HP_0002900 |
T26 | 6560-6571 | Phenotype | denotes | Hypokalemia | http://purl.obolibrary.org/obo/HP_0002900 |
T27 | 7173-7185 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T28 | 7244-7256 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T29 | 7472-7484 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T30 | 7960-7972 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T31 | 8492-8516 | Phenotype | denotes | congestive heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T32 | 10480-10491 | Phenotype | denotes | myocarditis | http://purl.obolibrary.org/obo/HP_0012819 |
T33 | 10911-10931 | Phenotype | denotes | ST-segment elevation | http://purl.obolibrary.org/obo/HP_0012251 |
T34 | 10932-10953 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T35 | 11021-11058 | Phenotype | denotes | left ventricular systolic dysfunction | http://purl.obolibrary.org/obo/HP_0025169 |
T36 | 11066-11090 | Phenotype | denotes | left ventricular failure | http://purl.obolibrary.org/obo/HP_0005162 |
T37 | 11095-11112 | Phenotype | denotes | cardiogenic shock | http://purl.obolibrary.org/obo/HP_0030149 |
T38 | 11188-11201 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T39 | 11228-11241 | Phenotype | denotes | Heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T40 | 11374-11385 | Phenotype | denotes | Arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T41 | 11408-11419 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T42 | 11567-11577 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T43 | 11723-11733 | Phenotype | denotes | arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
T44 | 12391-12419 | Phenotype | denotes | respiratory tract infections | http://purl.obolibrary.org/obo/HP_0011947 |
T45 | 15019-15039 | Phenotype | denotes | ST-segment elevation | http://purl.obolibrary.org/obo/HP_0012251 |
T46 | 15040-15061 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T47 | 16389-16408 | Phenotype | denotes | prolong QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
T48 | 16736-16755 | Phenotype | denotes | prolong QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
T49 | 16800-16819 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 317-326 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | virulence |
T3 | 317-326 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | virulence |
T4 | 1198-1210 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T5 | 1423-1435 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T6 | 2416-2434 | http://purl.obolibrary.org/obo/GO_0006006 | denotes | glucose metabolism |
T7 | 2424-2434 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T8 | 2457-2468 | http://purl.obolibrary.org/obo/GO_0042592 | denotes | homeostasis |
T9 | 3572-3581 | http://purl.obolibrary.org/obo/GO_0007612 | denotes | learnings |
T10 | 4953-4963 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
T11 | 5103-5121 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathways |
T12 | 5103-5112 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T13 | 5187-5199 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T14 | 5267-5288 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
T15 | 5826-5838 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T16 | 6024-6036 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T17 | 10518-10530 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T18 | 12195-12211 | http://purl.obolibrary.org/obo/GO_0006629 | denotes | lipid metabolism |
T19 | 12201-12211 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T20 | 12284-12302 | http://purl.obolibrary.org/obo/GO_0006006 | denotes | glucose metabolism |
T21 | 12292-12302 | http://purl.obolibrary.org/obo/GO_0008152 | denotes | metabolism |
T22 | 14963-14975 | http://purl.obolibrary.org/obo/GO_0042730 | denotes | fibrinolysis |
T23 | 16028-16043 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T23 | 0-15 | Sentence | denotes | 1 Introduction |
T24 | 16-221 | Sentence | denotes | The emergence of novel coronavirus, officially known as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an unprecedented challenge for the healthcare community across the world. |
T25 | 222-426 | Sentence | denotes | High infectivity, ability to get transmitted even during asymptomatic phase and relatively low virulence have resulted in rapid transmission of this virus beyond geographic regions, leading to a pandemic. |
T26 | 427-571 | Sentence | denotes | The first case of this disease, known as coronavirus disease 2019 (COVID-2019), occurred on December 8, 2019 in the Hubei province of China [1]. |
T27 | 572-814 | Sentence | denotes | Since then, within a short span of just over 3 months, the infection has spread to 177 countries/area/territories across the world, with 266073 confirmed cases and 11184 deaths (World Health Organization statistics as on March 21, 2020) [2] . |
T28 | 815-880 | Sentence | denotes | Table 1 Cardiovascular complications in coronavirus disease 2019. |
T29 | 881-912 | Sentence | denotes | Manifestation Incidence Remarks |
T30 | 913-1111 | Sentence | denotes | Acute cardiac injury∗ (most commonly defined as elevation of cardiac troponin I above 99th percentile upper reference limit) 8–12% on average [10] • Most commonly reported cardiovascular abnormality |
T31 | 1112-1187 | Sentence | denotes | • Can result from any of the following mechanisms-•Direct myocardial injury |
T32 | 1188-1210 | Sentence | denotes | •Systemic inflammation |
T33 | 1211-1252 | Sentence | denotes | •Myocardial oxygen demand supply mismatch |
T34 | 1253-1274 | Sentence | denotes | •Acute coronary event |
T35 | 1275-1286 | Sentence | denotes | •Iatrogenic |
T36 | 1287-1320 | Sentence | denotes | • Strong adverse prognostic value |
T37 | 1321-1458 | Sentence | denotes | Acute coronary event Not reported, but appears to be low Potential mechanisms-• Plaque rupture due to inflammation/increased shear stress |
T38 | 1459-1512 | Sentence | denotes | • Aggravation of pre-existing coronary artery disease |
T39 | 1513-1679 | Sentence | denotes | Left ventricular systolic dysfunction Not reported Any of the causes of myocardial dysfunction mentioned above can lead to acute left ventricular systolic dysfunction |
T40 | 1680-1884 | Sentence | denotes | Heart failure Reported in one study- 52% in those who died, 12% in those who recovered and were discharged [5] • Any of the causes of myocardial dysfunction mentioned above can lead to acute heart failure |
T41 | 1885-2003 | Sentence | denotes | • Increased metabolic demand of a systemic disease can cause acute decompensation of pre-existing stable heart failure |
T42 | 2004-2158 | Sentence | denotes | Arrhythmia 16.7% overall; 44.4 in severe illness, 8.9% in mild cases [8] Both tachyarrhythmia and bradyarrhythmia can occur but exact nature not described |
T43 | 2159-2264 | Sentence | denotes | Potential long-term consequences Too early to assess Too early to ascertain for coronavirus disease 2019. |
T44 | 2265-2473 | Sentence | denotes | However, patients recovering from a similar earlier illness- Severe Acute Respiratory Syndrome- continued to have long-term abnormalities of lipid and glucose metabolism and of cardiovascular homeostasis [12] |
T45 | 2474-2704 | Sentence | denotes | ∗ Acute cardiac injury is a non-specific term with significant overlap with other cardiovascular manifestations; however, it is listed here because of how reporting has been done in most of the studies on coronavirus disease 2019. |
T46 | 2705-2898 | Sentence | denotes | Respiratory involvement, presenting as mild flulike illness to potentially lethal acute respiratory distress syndrome or fulminant pneumonia, is the dominant clinical manifestation of COVID-19. |
T47 | 2899-3053 | Sentence | denotes | However, much like any other respiratory tract infection, pre-existing cardiovascular disease (CVD) and CV risk factors enhance vulnerability to COVID-19. |
T48 | 3054-3149 | Sentence | denotes | Further, COVID-19 can worsen underlying CVD and even precipitate de novo cardiac complications. |
T49 | 3150-3259 | Sentence | denotes | This review is aimed at providing overview of various CV manifestations in patients presenting with COVID-19. |
T50 | 3260-3384 | Sentence | denotes | The impact of pre-existing CVD and new onset cardiac complications on clinical outcomes in these patients is also discussed. |
T51 | 3385-3679 | Sentence | denotes | Since our understanding on this subject is only evolving at this stage, the information contained in the subsequent text is based mainly on the limited early experience with COVID-19 and learnings from the previous coronavirus illnesses, namely SARS and Middle-East Respiratory Syndrome (MERS). |
T52 | 3681-3698 | Sentence | denotes | 2 Search methods |
T53 | 3699-3924 | Sentence | denotes | A literature search was done using PubMed and Google search engines for original and review articles, advisories from professional societies, and expert commentaries published since the onset of the current COVID-19 epidemic. |
T54 | 3925-4096 | Sentence | denotes | Search terms “COVID-19” and “coronavirus” were used in combination with “cardiac”, “cardiovascular”, “arrhythmia”, “myocardial infarction”, “troponin” and “heart failure”. |
T55 | 4097-4183 | Sentence | denotes | Relevant cross-references for previous studies about SARS and MERS were also reviewed. |
T56 | 4185-4215 | Sentence | denotes | 2.1 Pathogenic considerations |
T57 | 4216-4279 | Sentence | denotes | SARS-CoV-2 is caused by a novel enveloped RNA beta-coronavirus. |
T58 | 4280-4509 | Sentence | denotes | Seven species of these beta-coronaviruses are known to cause human infections, with four mainly causing mild flulike symptoms and the remaining three resulting in potentially fatal illnesses (SARS, MERS and the ongoing COVID-19). |
T59 | 4510-4628 | Sentence | denotes | Although respiratory tract is the primary target for SARS-CoV-2, CV system may get involved in several different ways. |
T60 | 4629-4718 | Sentence | denotes | Following are the common mechanisms responsible for CV complications in COVID-19 [3,4]-1. |
T61 | 4720-4907 | Sentence | denotes | Direct myocardial injury- SARS-CoV-2 enters human cells by binding to angiotensin-converting enzyme 2 (ACE2), a membrane bound aminopeptidase which is highly expressed in heart and lungs. |
T62 | 4908-5035 | Sentence | denotes | ACE2 plays an important role in neurohumoral regulation of CV system in normal health as well as in various disease conditions. |
T63 | 5036-5173 | Sentence | denotes | The binding of SARS-CoV-2 to ACE2 can result in alteration of ACE2 signaling pathways, leading to acute myocardial and lung injury [3,4]. |
T64 | 5174-5176 | Sentence | denotes | 2. |
T65 | 5178-5385 | Sentence | denotes | Systemic inflammation- More severe forms of COVID-19 are characterized by acute systemic inflammatory response and cytokine storm, which can result in injury to multiple organs leading to multiorgan failure. |
T66 | 5386-5506 | Sentence | denotes | Studies have shown high circulatory levels of proinflammatory cytokines in patients with severe/critical COVID-19 [5,6]. |
T67 | 5507-5509 | Sentence | denotes | 3. |
T68 | 5511-5772 | Sentence | denotes | Altered myocardial demand-supply ratio- Increased cardiometabolic demand associated with the systemic infection coupled with hypoxia caused by acute respiratory illness can impair myocardial oxygen demand-supply relationship and lead to acute myocardial injury. |
T69 | 5773-5775 | Sentence | denotes | 4. |
T70 | 5777-5982 | Sentence | denotes | Plaque rupture and coronary thrombosis- Systemic inflammation as well as increased shear stress due to increased coronary blood flow can precipitate plaque rupture resulting in acute myocardial infarction. |
T71 | 5983-6064 | Sentence | denotes | Prothrombotic milieu created by systemic inflammation further increases the risk. |
T72 | 6065-6067 | Sentence | denotes | 5. |
T73 | 6069-6246 | Sentence | denotes | Adverse effects of various therapies- Various antiviral drugs, corticosteroids and other therapies aimed at treating COVID-19 can also have deleterious effects on the CV system. |
T74 | 6247-6249 | Sentence | denotes | 6. |
T75 | 6251-6420 | Sentence | denotes | Electrolyte imbalances- Electrolyte imbalances can occur in any critical systemic illness and precipitate arrhythmias, esp. in patients with underlying cardiac disorder. |
T76 | 6421-6559 | Sentence | denotes | There is particular concern about hypokalemia in COVID-19, due to interaction of SARS-CoV-2 with renin-angiotensin-aldosterone system [7]. |
T77 | 6560-6624 | Sentence | denotes | Hypokalemia increases vulnerability to various tachyarrhythmias. |
T78 | 6626-6667 | Sentence | denotes | 2.1.1 Role of underling CV comorbidities |
T79 | 6668-6839 | Sentence | denotes | The patients with pre-existing CVD appear to have heightened vulnerability to develop COVID-19 and tend to have more severe disease with worse clinical outcomes [1,4,6,8]. |
T80 | 6840-6992 | Sentence | denotes | Various CV risk factors also adversely affect porgnosis of these patients, although they do not seem to increase likleihood of developing the infection. |
T81 | 6993-7203 | Sentence | denotes | A meta-analysis of six published studies from China including 1527 patients with COVID-19 reported 9.7%, 16.4% and 17.1% prevalence of diabetes, cardio-cerebrovascular disease and hypertension respectively [4]. |
T82 | 7204-7392 | Sentence | denotes | Although the prevalence of diabetes and hypertension in this cohort was same as in the Chinese general population, the prevalence of cardio-cerebrovascular disease was considerably higher. |
T83 | 7393-7666 | Sentence | denotes | More importantly, the presence of diabetes, cardio-cerebrovascular disease and hypertension was associated with a 2-fold, 3-fold and 2-fold greater risk of severe disease or requiring intensive care unit (ICU) admission, suggesting prognostic impact of these comorbidities. |
T84 | 7667-7816 | Sentence | denotes | A much larger report from the Chinese Center for Disease Control and Prevention described clinical outcomes in 44672 confirmed cases of COVID-19 [1]. |
T85 | 7817-7991 | Sentence | denotes | The overall case fatality rate (CFR) was 2.3% in the entire cohort but significantly higher (6%, 7.3% and 10.5% respectively) in patients with hypertension, diabetes and CVD. |
T86 | 7992-8163 | Sentence | denotes | Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. |
T87 | 8164-8291 | Sentence | denotes | The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. |
T88 | 8292-8414 | Sentence | denotes | A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. |
T89 | 8415-8526 | Sentence | denotes | Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. |
T90 | 8527-8604 | Sentence | denotes | Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. |
T91 | 8605-8844 | Sentence | denotes | However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome. |
T92 | 8846-8892 | Sentence | denotes | 2.2 Cardiovascular manifestations of COVID-19 |
T93 | 8894-8924 | Sentence | denotes | 2.2.1 Acute myocardial injury |
T94 | 8925-9018 | Sentence | denotes | Acute myocardial injury is the most commonly described CV complication in COVID-19 (Table 1). |
T95 | 9019-9210 | Sentence | denotes | Different reports have used different definitions for acute myocardial injury, including rise in cardiac enzymes (different biomarkers and cut-offs) and/or electrocardiographic abnormalities. |
T96 | 9211-9367 | Sentence | denotes | However, an elevation of high-sensitivity cardiac troponin I (cTnI) above 99th percentile upper reference limit is the most commonly used definition.Table 1 |
T97 | 9368-9528 | Sentence | denotes | The overall incidence of acute cardiac injury has been variable but roughly 8–12% of the positive cases are known to develop significant elevation of cTnI [10]. |
T98 | 9529-9798 | Sentence | denotes | The aforementioned meta-analysis of the Chinese studies [4] reported 8% incidence of acute cardiac injury whereas another study including only those patients who had had a definite outcome (death or discharge from hospital) reported 17% incidence of cTnI elevation [5]. |
T99 | 9799-9960 | Sentence | denotes | Regardless of the actual incidence, acute cardiac injury has been consistently shown to be a strong negative prognostic marker in patients with COVID-19 [5,6,8]. |
T100 | 9961-10079 | Sentence | denotes | The patients admitted to ICU or having severe/fatal illness have several-fold higher likelihood of troponin elevation. |
T101 | 10080-10218 | Sentence | denotes | In contrast, the incidence of elevated troponin has been very low (only 1–2%) in patients having mild illness not requiring ICU admission. |
T102 | 10219-10346 | Sentence | denotes | Any of the mechanisms described above can lead to acute cardiac injury and rise in cardiac troponins in patients with COVID-19. |
T103 | 10347-10571 | Sentence | denotes | The relative role of these different mechanisms has not been described but direct (i.e. non-coronary) myocardial injury due to viral myocarditis or the effect of systemic inflammation appear to be the most common mechanisms. |
T104 | 10572-10708 | Sentence | denotes | These observations are supported by a previous autopsy study in patients who had died due to SARS during the Toronto SARS outbreak [11]. |
T105 | 10709-10870 | Sentence | denotes | In this study, the viral ribonucleic acid was detected in 35% of the autopsied human heart samples, providing evidence for direct myocardial injury by the virus. |
T106 | 10871-10992 | Sentence | denotes | No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. |
T107 | 10993-11142 | Sentence | denotes | Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. |
T108 | 11143-11227 | Sentence | denotes | Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. |
T109 | 11228-11365 | Sentence | denotes | Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital. |
T110 | 11367-11385 | Sentence | denotes | 2.2.2 Arrhythmias |
T111 | 11386-11451 | Sentence | denotes | Both tachy- and brady-arrhythmias are known to occur in COVID-19. |
T112 | 11452-11582 | Sentence | denotes | A study describing clinical profile and outcomes in 138 Chinese patients with COVID-19 reported 16.7% incidence of arrhythmia [8]. |
T113 | 11583-11710 | Sentence | denotes | The incidence was much higher (44.4%) in those requiring ICU admission as compared to those not requiring ICU admission (8.9%). |
T114 | 11711-11752 | Sentence | denotes | The type of arrhythmia was not described. |
T115 | 11754-11793 | Sentence | denotes | 2.2.3 Potential long-term consequences |
T116 | 11794-11932 | Sentence | denotes | COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. |
T117 | 11933-12090 | Sentence | denotes | However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. |
T118 | 12091-12315 | Sentence | denotes | It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. |
T119 | 12316-12425 | Sentence | denotes | Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. |
T120 | 12426-12629 | Sentence | denotes | Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD. |
T121 | 12631-12659 | Sentence | denotes | 2.3 Management implications |
T122 | 12660-12841 | Sentence | denotes | The overall management principles for patients presenting with COVID-19 who develop CV complications or who have pre-existing CVD are same as for any other patient without COVID-19. |
T123 | 12842-12910 | Sentence | denotes | However, there are a few important points that need consideration-1. |
T124 | 12911-13031 | Sentence | denotes | As caregivers, it is our utmost responsibility to protect ourselves from getting infected while managing these patients. |
T125 | 13032-13156 | Sentence | denotes | Therefore, all heathcare personnel engaged in the care of COVID-19 patients must observe necessary precautions at all times. |
T126 | 13157-13307 | Sentence | denotes | All of them should be trained in donning, usage, and doffing of the personal protective equipment in accordance with the existing practice guidelines. |
T127 | 13308-13310 | Sentence | denotes | 2. |
T128 | 13311-13471 | Sentence | denotes | The hospital systems need to ensure preparedness for dealing with large volume of COVID-19 patients, many of whom would need ICU care and/or acute cardiac care. |
T129 | 13472-13631 | Sentence | denotes | Appropriate protocols for rapid diagnosis, triage, isolation, and management of COVID-19 patients with CV complications should be developed and well-rehearsed. |
T130 | 13632-13800 | Sentence | denotes | Rapid triaging and management of these patients is crucial, not only to allow efficient utilization of healthcare resources but also to minimize exposure to caregivers. |
T131 | 13801-13955 | Sentence | denotes | There are already reports highlighting delays in delivering acute cardiac care due to extra precautions that need to be observed in view of COVID-19 [14]. |
T132 | 13956-14003 | Sentence | denotes | Efforts should be made to minimize such delays. |
T133 | 14004-14006 | Sentence | denotes | 3. |
T134 | 14007-14147 | Sentence | denotes | Strong emphasis should be placed on avoiding unwarranted diagnostic tests (e.g. cardiac troponin, echocardiography, etc.) in these patients. |
T135 | 14148-14381 | Sentence | denotes | This is required to minimize unwarranted downstream diagnostic/therapeutic procedures which would further strain the already stretched healthcare resources and would also subject caregivers to added risk of exposure to the infection. |
T136 | 14382-14544 | Sentence | denotes | The American College of Cardiology has released an advisory discouraging random measurement of cardiac biomarkers such as troponins and natriuretic peptides [15]. |
T137 | 14545-14709 | Sentence | denotes | It urges all the clinicians to reserve these assays for circumstances in which they would actually meaningfully add to the management of the patients with COVID-19. |
T138 | 14710-14847 | Sentence | denotes | The American Society of Echocardiography has also issued a similar advisory regarding the use of echocardiography in these patients [16]. |
T139 | 14848-14850 | Sentence | denotes | 4. |
T140 | 14851-15062 | Sentence | denotes | The individual hospitals may also have to reconsider risk-benefit ratio of primary percutaneous intervention vs fibrinolysis in patients with COVID-19 who present with ST-segment elevation myocardial infarction. |
T141 | 15063-15065 | Sentence | denotes | 5. |
T142 | 15066-15214 | Sentence | denotes | There has been a concern regarding the safety of ACE inhibitors (ACEi) and angiotensin receptor blockers (ARB) during the ongoing COVID-19 pandemic. |
T143 | 15215-15311 | Sentence | denotes | These agents upregulate expression of ACE2 in various tissues, including on cardiomyocytes [17]. |
T144 | 15312-15536 | Sentence | denotes | Since SARS-CoV-2 binds to ACE2 to gain entry into human cells, there is a potentially increased risk of developing COVID-19 or developing more severe disease in patients who are already on background treatment with ACEi/ARB. |
T145 | 15537-15627 | Sentence | denotes | However, to date, no experimental or clinical data have emerged to support these concerns. |
T146 | 15628-15704 | Sentence | denotes | At the same time, the risks of discontinuing these therapies are well known. |
T147 | 15705-15883 | Sentence | denotes | Therefore, several leading professional societies have strongly urged to not discontinue clinically-indicated ACEi/ARB therapy in the event the patient develops COVID-19 [18,19]. |
T148 | 15884-15886 | Sentence | denotes | 6. |
T149 | 15887-16044 | Sentence | denotes | Clinicians caring for these patients also need to be fully aware of the potential CV side-effects of various therapies used for treating the viral infection. |
T150 | 16045-16206 | Sentence | denotes | Additionally, various anti-retroviral drugs have significant interactions with cardiac drugs, which need to be considered and appropriate dose modification done. |
T151 | 16207-16358 | Sentence | denotes | More recently, chloroquine/hydroxychloroquine and azathioprine have been proposed as potential therapeutic options, based on preliminary evidence [20]. |
T152 | 16359-16473 | Sentence | denotes | Both these drugs are known to prolong QT interval and due caution must be exercised when prescribing these agents. |
T153 | 16474-16756 | Sentence | denotes | Their combination is best avoided and even when using chloroquine/hydroxychloroquine alone, daily electrocardiogram for monitoring QT interval is warranted, esp. in patients with hepatic or renal dysfunction and in those receiving another drug with potential to prolong QT interval. |
T154 | 16758-16790 | Sentence | denotes | 3 Summary and future directions |
T155 | 16791-17068 | Sentence | denotes | Although respiratory illness is the dominant clinical manifestation of COVID-19, the shear burden of the illness implies that a large number of patients with COVID-19 would present with pre-existing CVD or develop new-onset cardiac dysfunction during the course of the illness. |
T156 | 17069-17180 | Sentence | denotes | Considering this, the current understanding about the interplay between CVD and COVID-19 is grossly inadequate. |
T157 | 17181-17381 | Sentence | denotes | It is therefore highly desirable that the future studies on COVID-19 specifically describe the incidence, mechanisms, clinical presentation and outcomes of various CV manifestations in these patients. |
T158 | 17382-17507 | Sentence | denotes | The diagnostic and therapeutic challenges posed by the concurrence of these two illnesses also need to be adequately studied. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T38 | 39-50 | NCBITaxon:11118 | denotes | coronavirus |
T39 | 72-119 | SP_7 | denotes | Severe Acute Respiratory Syndrome-Coronavirus-2 |
T40 | 121-131 | SP_7 | denotes | SARS-CoV-2 |
T41 | 371-376 | NCBITaxon:10239 | denotes | virus |
T42 | 468-479 | NCBITaxon:11118 | denotes | coronavirus |
T43 | 742-748 | GO:0016265 | denotes | deaths |
T44 | 855-866 | NCBITaxon:11118 | denotes | coronavirus |
T45 | 919-926 | UBERON:0000948 | denotes | cardiac |
T46 | 974-981 | UBERON:0000948 | denotes | cardiac |
T47 | 1085-1099 | UBERON:0004535 | denotes | cardiovascular |
T48 | 1170-1180 | UBERON:0002349 | denotes | myocardial |
T49 | 1212-1222 | UBERON:0002349 | denotes | Myocardial |
T50 | 1260-1268 | UBERON:0001621 | denotes | coronary |
T51 | 1327-1335 | UBERON:0001621 | denotes | coronary |
T52 | 1489-1504 | UBERON:0001621 | denotes | coronary artery |
T53 | 1518-1529 | UBERON:0002082 | denotes | ventricular |
T54 | 1585-1595 | UBERON:0002349 | denotes | myocardial |
T55 | 1642-1658 | UBERON:0002084 | denotes | left ventricular |
T56 | 1734-1738 | GO:0016265 | denotes | died |
T57 | 1814-1824 | UBERON:0002349 | denotes | myocardial |
T58 | 1871-1876 | UBERON:0000948 | denotes | heart |
T59 | 1897-1906 | GO:0008152 | denotes | metabolic |
T60 | 1990-1995 | UBERON:0000948 | denotes | heart |
T61 | 2239-2250 | NCBITaxon:11118 | denotes | coronavirus |
T62 | 2406-2411 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
T63 | 2416-2423 | CHEBI:17234;CHEBI:17234;GO:0006006 | denotes | glucose |
T64 | 2424-2434 | GO:0006006 | denotes | metabolism |
T65 | 2442-2456 | UBERON:0004535 | denotes | cardiovascular |
T66 | 2457-2468 | GO:0042592 | denotes | homeostasis |
T67 | 2482-2489 | UBERON:0000948 | denotes | cardiac |
T68 | 2556-2570 | UBERON:0004535 | denotes | cardiovascular |
T69 | 2679-2690 | NCBITaxon:11118 | denotes | coronavirus |
T88 | 2793-2804 | UBERON:0001004 | denotes | respiratory |
T89 | 2889-2897 | SP_7 | denotes | COVID-19 |
T90 | 2928-2945 | UBERON:0000065 | denotes | respiratory tract |
T91 | 2970-2984 | UBERON:0004535 | denotes | cardiovascular |
T92 | 3044-3052 | SP_7 | denotes | COVID-19 |
T93 | 3063-3071 | SP_7 | denotes | COVID-19 |
T94 | 3127-3134 | UBERON:0000948 | denotes | cardiac |
T95 | 3250-3258 | SP_7 | denotes | COVID-19 |
T96 | 3305-3312 | UBERON:0000948 | denotes | cardiac |
T97 | 3559-3567 | SP_7 | denotes | COVID-19 |
T98 | 3572-3581 | GO:0007612 | denotes | learnings |
T99 | 3600-3611 | NCBITaxon:11118 | denotes | coronavirus |
T100 | 3630-3634 | SP_10 | denotes | SARS |
T101 | 3673-3677 | SP_9 | denotes | MERS |
T102 | 3906-3914 | SP_7 | denotes | COVID-19 |
T103 | 3939-3947 | SP_7 | denotes | COVID-19 |
T104 | 3954-3965 | NCBITaxon:11118 | denotes | coronavirus |
T105 | 3998-4005 | UBERON:0000948 | denotes | cardiac |
T106 | 4009-4023 | UBERON:0004535 | denotes | cardiovascular |
T107 | 4041-4051 | UBERON:0002349 | denotes | myocardial |
T108 | 4081-4086 | UBERON:0000948 | denotes | heart |
T109 | 4150-4154 | SP_10 | denotes | SARS |
T110 | 4159-4163 | SP_9 | denotes | MERS |
T111 | 4216-4226 | SP_7 | denotes | SARS-CoV-2 |
T112 | 4267-4278 | NCBITaxon:11118 | denotes | coronavirus |
T113 | 4286-4293 | NCBITaxon:species | denotes | species |
T114 | 4308-4321 | NCBITaxon:11118 | denotes | coronaviruses |
T115 | 4341-4346 | SP_6;NCBITaxon:9606 | denotes | human |
T116 | 4472-4476 | SP_10 | denotes | SARS |
T117 | 4478-4482 | SP_9 | denotes | MERS |
T118 | 4499-4507 | SP_7 | denotes | COVID-19 |
T119 | 4519-4536 | UBERON:0000065 | denotes | respiratory tract |
T120 | 4563-4573 | SP_7 | denotes | SARS-CoV-2 |
T121 | 4701-4709 | SP_7 | denotes | COVID-19 |
T122 | 4727-4737 | UBERON:0002349 | denotes | myocardial |
T123 | 4746-4756 | SP_7 | denotes | SARS-CoV-2 |
T124 | 4764-4769 | SP_6;NCBITaxon:9606 | denotes | human |
T125 | 4790-4821 | PG_10;PR:000003622 | denotes | angiotensin-converting enzyme 2 |
T126 | 4823-4827 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T127 | 4832-4840 | GO:0016020 | denotes | membrane |
T128 | 4878-4887 | GO:0010467 | denotes | expressed |
T129 | 4891-4896 | UBERON:0000948 | denotes | heart |
T130 | 4901-4906 | UBERON:0000170 | denotes | lungs |
T131 | 4908-4912 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T132 | 4953-4963 | GO:0065007 | denotes | regulation |
T133 | 4967-4969 | UBERON:0001017 | denotes | CV |
T134 | 5051-5061 | SP_7 | denotes | SARS-CoV-2 |
T135 | 5065-5069 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T136 | 5098-5102 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T137 | 5140-5150 | UBERON:0002349 | denotes | myocardial |
T138 | 5155-5159 | UBERON:0002048 | denotes | lung |
T177 | 5222-5230 | SP_7 | denotes | COVID-19 |
T178 | 5348-5354 | UBERON:0000062 | denotes | organs |
T179 | 5366-5376 | UBERON:0000062 | denotes | multiorgan |
T180 | 5491-5499 | SP_7 | denotes | COVID-19 |
T181 | 5519-5529 | UBERON:0002349 | denotes | myocardial |
T182 | 5660-5671 | UBERON:0001004 | denotes | respiratory |
T183 | 5691-5701 | UBERON:0002349 | denotes | myocardial |
T184 | 5754-5764 | UBERON:0002349 | denotes | myocardial |
T185 | 5796-5804 | UBERON:0005985 | denotes | coronary |
T186 | 5805-5815 | GO:0007596 | denotes | thrombosis |
T187 | 5890-5898 | UBERON:0005985 | denotes | coronary |
T188 | 5899-5904 | UBERON:0000178 | denotes | blood |
T189 | 5960-5970 | UBERON:0002349 | denotes | myocardial |
T190 | 5983-5996 | GO:0007596 | denotes | Prothrombotic |
T191 | 6125-6130 | CHEBI:36044;CHEBI:36044 | denotes | drugs |
T192 | 6132-6147 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T193 | 6186-6194 | SP_7 | denotes | COVID-19 |
T194 | 6403-6410 | UBERON:0000948 | denotes | cardiac |
T195 | 6470-6478 | SP_7 | denotes | COVID-19 |
T196 | 6502-6512 | SP_7 | denotes | SARS-CoV-2 |
T197 | 6518-6523 | PR:000013883 | denotes | renin |
T198 | 6754-6762 | SP_7 | denotes | COVID-19 |
T199 | 7074-7082 | SP_7 | denotes | COVID-19 |
T200 | 7145-7160 | UBERON:0002037 | denotes | cerebrovascular |
T201 | 7344-7359 | UBERON:0002037 | denotes | cerebrovascular |
T202 | 7444-7459 | UBERON:0002037 | denotes | cerebrovascular |
T203 | 7587-7591 | CL:0000037 | denotes | care |
T204 | 7803-7811 | SP_7 | denotes | COVID-19 |
T205 | 8503-8508 | UBERON:0000948 | denotes | heart |
T206 | 8533-8540 | UBERON:0000948 | denotes | cardiac |
T207 | 8599-8603 | GO:0016265 | denotes | died |
T208 | 8679-8685 | GO:0016265 | denotes | deaths |
T209 | 8851-8865 | UBERON:0004535 | denotes | Cardiovascular |
T210 | 8884-8892 | SP_7 | denotes | COVID-19 |
T211 | 8907-8917 | UBERON:0002349 | denotes | myocardial |
T212 | 8931-8941 | UBERON:0002349 | denotes | myocardial |
T213 | 8999-9007 | SP_7 | denotes | COVID-19 |
T214 | 9079-9089 | UBERON:0002349 | denotes | myocardial |
T215 | 9116-9123 | UBERON:0000948 | denotes | cardiac |
T216 | 9253-9260 | UBERON:0000948 | denotes | cardiac |
T217 | 9399-9406 | UBERON:0000948 | denotes | cardiac |
T218 | 9620-9627 | UBERON:0000948 | denotes | cardiac |
T219 | 9719-9724 | GO:0016265 | denotes | death |
T220 | 9841-9848 | UBERON:0000948 | denotes | cardiac |
T221 | 9943-9951 | SP_7 | denotes | COVID-19 |
T222 | 10275-10282 | UBERON:0000948 | denotes | cardiac |
T223 | 10302-10309 | UBERON:0000948 | denotes | cardiac |
T224 | 10337-10345 | SP_7 | denotes | COVID-19 |
T225 | 10439-10447 | UBERON:0001621 | denotes | coronary |
T226 | 10449-10459 | UBERON:0002349 | denotes | myocardial |
T227 | 10474-10479 | NCBITaxon:10239 | denotes | viral |
T228 | 10653-10657 | GO:0016265 | denotes | died |
T229 | 10665-10669 | SP_10 | denotes | SARS |
T230 | 10689-10693 | SP_10 | denotes | SARS |
T231 | 10728-10733 | NCBITaxon:10239 | denotes | viral |
T232 | 10788-10793 | SP_6;NCBITaxon:9606 | denotes | human |
T233 | 10794-10799 | UBERON:0000948 | denotes | heart |
T234 | 10839-10849 | UBERON:0002349 | denotes | myocardial |
T235 | 10864-10869 | NCBITaxon:10239 | denotes | virus |
T236 | 10932-10942 | UBERON:0002349 | denotes | myocardial |
T237 | 10957-10965 | SP_7 | denotes | COVID-19 |
T238 | 11021-11037 | UBERON:0002084 | denotes | left ventricular |
T239 | 11066-11082 | UBERON:0002084 | denotes | left ventricular |
T240 | 11188-11193 | UBERON:0000948 | denotes | heart |
T241 | 11205-11213 | SP_7 | denotes | COVID-19 |
T242 | 11228-11233 | UBERON:0000948 | denotes | Heart |
T243 | 11295-11299 | GO:0016265 | denotes | died |
T244 | 11442-11450 | SP_7 | denotes | COVID-19 |
T245 | 11530-11538 | SP_7 | denotes | COVID-19 |
T246 | 11794-11802 | SP_7 | denotes | COVID-19 |
T247 | 11957-11965 | CHEBI:33695;CHEBI:33695;SO:0000673 | denotes | messages |
T248 | 12012-12016 | SP_10 | denotes | SARS |
T249 | 12028-12036 | SP_10 | denotes | SARS-CoV |
T250 | 12079-12089 | SP_7 | denotes | SARS-CoV-2 |
T251 | 12150-12154 | SP_10 | denotes | SARS |
T252 | 12195-12200 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | lipid |
T253 | 12201-12211 | GO:0006629 | denotes | metabolism |
T254 | 12284-12291 | CHEBI:17234;CHEBI:17234;GO:0006006 | denotes | glucose |
T255 | 12292-12302 | GO:0006006 | denotes | metabolism |
T256 | 12391-12408 | UBERON:0000065 | denotes | respiratory tract |
T257 | 12499-12507 | SP_7 | denotes | COVID-19 |
T258 | 12723-12731 | SP_7 | denotes | COVID-19 |
T259 | 12832-12840 | SP_7 | denotes | COVID-19 |
T260 | 13090-13098 | SP_7 | denotes | COVID-19 |
T261 | 13393-13401 | SP_7 | denotes | COVID-19 |
T262 | 13458-13465 | UBERON:0000948 | denotes | cardiac |
T263 | 13552-13560 | SP_7 | denotes | COVID-19 |
T264 | 13850-13860 | GO:0007567 | denotes | delivering |
T265 | 13867-13874 | UBERON:0000948 | denotes | cardiac |
T266 | 13941-13949 | SP_7 | denotes | COVID-19 |
T267 | 14087-14094 | UBERON:0000948 | denotes | cardiac |
T268 | 14406-14416 | UBERON:0000948 | denotes | Cardiology |
T269 | 14477-14484 | UBERON:0000948 | denotes | cardiac |
T270 | 14700-14708 | SP_7 | denotes | COVID-19 |
T271 | 14963-14975 | GO:0042730 | denotes | fibrinolysis |
T272 | 14993-15001 | SP_7 | denotes | COVID-19 |
T273 | 15040-15050 | UBERON:0002349 | denotes | myocardial |
T274 | 15119-15129 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T275 | 15153-15170 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
T276 | 15196-15204 | SP_7 | denotes | COVID-19 |
T277 | 15239-15249 | GO:0010467 | denotes | expression |
T278 | 15253-15257 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T279 | 15269-15276 | UBERON:0000479 | denotes | tissues |
T280 | 15291-15305 | CL:0000746 | denotes | cardiomyocytes |
T281 | 15318-15328 | SP_7 | denotes | SARS-CoV-2 |
T282 | 15338-15342 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T283 | 15362-15367 | SP_6;NCBITaxon:9606 | denotes | human |
T284 | 15427-15435 | SP_7 | denotes | COVID-19 |
T285 | 15866-15874 | SP_7 | denotes | COVID-19 |
T286 | 16028-16033 | NCBITaxon:10239 | denotes | viral |
T287 | 16067-16072 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
T288 | 16072-16082 | NCBITaxon:11632 | denotes | retroviral |
T289 | 16083-16088 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T290 | 16124-16131 | UBERON:0000948 | denotes | cardiac |
T291 | 16132-16137 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T292 | 16222-16233 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T293 | 16234-16252 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T294 | 16257-16269 | CHEBI:2948;CHEBI:2948 | denotes | azathioprine |
T295 | 16370-16375 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T296 | 16466-16472 | CHEBI:23888;CHEBI:23888 | denotes | agents |
T297 | 16528-16539 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T298 | 16540-16558 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T299 | 16653-16660 | UBERON:0002107 | denotes | hepatic |
T300 | 16664-16669 | UBERON:0002113 | denotes | renal |
T301 | 16713-16717 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T344 | 16800-16811 | UBERON:0001004 | denotes | respiratory |
T345 | 16862-16870 | SP_7 | denotes | COVID-19 |
T346 | 16949-16957 | SP_7 | denotes | COVID-19 |
T347 | 17015-17022 | UBERON:0000948 | denotes | cardiac |
T348 | 17149-17157 | SP_7 | denotes | COVID-19 |
T349 | 17241-17249 | SP_7 | denotes | COVID-19 |
T33 | 2482-2489 | UBERON:0000948 | denotes | cardiac |
T36 | 10275-10282 | UBERON:0000948 | denotes | cardiac |
T27626 | 10839-10849 | UBERON:0002349 | denotes | myocardial |
T52612 | 11026-11037 | UBERON:0002082 | denotes | ventricular |
T27094 | 11066-11082 | UBERON:0002084 | denotes | left ventricular |
T60649 | 16862-16870 | SP_7 | denotes | COVID-19 |
T90623 | 5718-5726 | SP_7 | denotes | pply rel |
T3419 | 5772-5780 | UBERON:0000948 | denotes | 4. Pla |
T78722 | 6028-6036 | SP_7 | denotes | ammation |
T53635 | 6041-6050 | GO:0007612 | denotes | her incre |
T94419 | 6070-6081 | NCBITaxon:11118 | denotes | dverse effe |
T38989 | 6100-6105 | SP_10 | denotes | apies |
T67414 | 6143-6147 | SP_9 | denotes | oids |
T60021 | 6377-6385 | SP_7 | denotes | patient |
T3699 | 6409-6417 | SP_7 | denotes | c disord |
T86101 | 6424-6435 | NCBITaxon:11118 | denotes | re is parti |
T88588 | 6468-6475 | UBERON:0000948 | denotes | n COVID |
T53986 | 6479-6493 | UBERON:0004535 | denotes | due to intera |
T35855 | 6511-6521 | UBERON:0002349 | denotes | 2 with ren |
T55568 | 6551-6556 | UBERON:0000948 | denotes | tem [ |
T45400 | 6620-6624 | SP_10 | denotes | ias. |
T96699 | 6630-6635 | SP_9 | denotes | 1 Ro |
T94696 | 6686-6697 | SP_7 | denotes | pre-existin |
T73378 | 6735-6746 | NCBITaxon:11118 | denotes | ability to |
T49479 | 6754-6761 | NCBITaxon:species | denotes | COVID-1 |
T49662 | 6773-6786 | NCBITaxon:11118 | denotes | o have more s |
T91764 | 6806-6811 | SP_6;NCBITaxon:9606 | denotes | orse |
T16144 | 6937-6941 | SP_10 | denotes | eem |
T61914 | 6943-6947 | SP_9 | denotes | inc |
T67143 | 6964-6972 | SP_7 | denotes | of devel |
T79419 | 6985-7003 | UBERON:0000065 | denotes | ection. A meta-ana |
T22287 | 7030-7042 | SP_7 | denotes | ies from Chi |
T48200 | 7170-7178 | SP_7 | denotes | nd hyper |
T78437 | 7195-7205 | UBERON:0002349 | denotes | ely [4]. A |
T61571 | 7214-7224 | SP_7 | denotes | he prevale |
T36103 | 7232-7237 | SP_6;NCBITaxon:9606 | denotes | iabet |
T42181 | 7258-7289 | PG_10;PR:000003622 | denotes | n this cohort was same as in th |
T13911 | 7291-7297 | G_3;PG_10;PR:000003622 | denotes | Chines |
T79903 | 7302-7310 | GO:0016020 | denotes | eral pop |
T50101 | 7348-7357 | GO:0010467 | denotes | brovascul |
T80107 | 7361-7366 | UBERON:0000948 | denotes | iseas |
T55772 | 7371-7376 | UBERON:0000170 | denotes | cons |
T53520 | 7378-7382 | G_3;PG_10;PR:000003622 | denotes | erab |
T48624 | 7423-7433 | GO:0065007 | denotes | of diabet |
T21124 | 7437-7439 | UBERON:0001017 | denotes | ca |
T78086 | 7521-7531 | SP_7 | denotes | and 2-fol |
T54232 | 7535-7539 | G_3;PG_10;PR:000003622 | denotes | eate |
T64983 | 7568-7572 | G_3;PG_10;PR:000003622 | denotes | equi |
T4317 | 7610-7620 | UBERON:0002349 | denotes | on, sugges |
T54741 | 7625-7629 | UBERON:0002048 | denotes | prog |
T139 | 7691-7701 | SP_7 | denotes | m the Chin |
T140 | 7818-7824 | UBERON:0000062 | denotes | he ove |
T141 | 7836-7845 | UBERON:0000062 | denotes | tality ra |
T142 | 7960-7968 | SP_7 | denotes | hyperten |
T143 | 7986-7996 | UBERON:0002349 | denotes | CVD. Alth |
T144 | 8124-8134 | UBERON:0001004 | denotes | across di |
T145 | 8156-8166 | UBERON:0002349 | denotes | ations. Th |
T146 | 8221-8231 | UBERON:0002349 | denotes | and many o |
T147 | 8262-8270 | UBERON:0005985 | denotes | in some |
T148 | 8271-8281 | GO:0007596 | denotes | uropean na |
T149 | 8356-8364 | UBERON:0005985 | denotes | tes of A |
T150 | 8365-8370 | UBERON:0000178 | denotes | erica |
T151 | 8425-8435 | UBERON:0002349 | denotes | ies were c |
T152 | 8448-8461 | GO:0007596 | denotes | cohort, with |
T153 | 8587-8592 | CHEBI:36044;CHEBI:36044 | denotes | 4% pa |
T154 | 8594-8609 | CHEBI:50858;CHEBI:50858 | denotes | ents died. Howe |
T155 | 8647-8655 | SP_7 | denotes | tes seem |
T156 | 8865-8872 | UBERON:0000948 | denotes | manife |
T157 | 8934-8942 | SP_7 | denotes | cardial |
T158 | 8966-8976 | SP_7 | denotes | nly descri |
T159 | 8982-8987 | PR:000013883 | denotes | comp |
T160 | 9099-9109 | UBERON:0002349 | denotes | ncluding r |
T161 | 9118-9128 | SP_7 | denotes | rdiac enzy |
T162 | 9136-9141 | SP_6;NCBITaxon:9606 | denotes | feren |
T163 | 9162-9195 | PG_10;PR:000003622 | denotes | offs) and/or electrocardiographic |
T164 | 9197-9201 | G_3;PG_10;PR:000003622 | denotes | bnor |
T165 | 9206-9214 | GO:0016020 | denotes | ies. How |
T166 | 9252-9261 | GO:0010467 | denotes | cardiac |
T167 | 9265-9270 | UBERON:0000948 | denotes | onin |
T168 | 9275-9280 | UBERON:0000170 | denotes | nI) a |
T169 | 9282-9286 | G_3;PG_10;PR:000003622 | denotes | ve 9 |
T170 | 9327-9337 | GO:0065007 | denotes | he most co |
T171 | 9341-9343 | UBERON:0001017 | denotes | ly |
T172 | 9425-9435 | SP_7 | denotes | riable but |
T173 | 9439-9443 | G_3;PG_10;PR:000003622 | denotes | ghly |
T174 | 9472-9476 | G_3;PG_10;PR:000003622 | denotes | are |
T175 | 9514-9524 | UBERON:0002349 | denotes | of cTnI [ |
T176 | 9529-9533 | UBERON:0002048 | denotes | The |
T64923 | 9599-9607 | SP_7 | denotes | % incide |
T13398 | 9724-9730 | UBERON:0000062 | denotes | or di |
T97031 | 9742-9752 | UBERON:0000062 | denotes | hospital) |
T12823 | 9867-9875 | SP_7 | denotes | nsistent |
T99017 | 9894-9904 | UBERON:0002349 | denotes | rong negat |
T3576 | 10032-10042 | UBERON:0001004 | denotes | l-fold hig |
T98428 | 10062-10072 | UBERON:0002349 | denotes | oponin ele |
T52387 | 10125-10135 | UBERON:0002349 | denotes | in has bee |
T17293 | 10166-10174 | UBERON:0005985 | denotes | nts havi |
T14874 | 10175-10185 | GO:0007596 | denotes | g mild ill |
T22127 | 10260-10268 | UBERON:0005985 | denotes | lead to |
T81653 | 10269-10274 | UBERON:0000178 | denotes | acute |
T33438 | 10329-10339 | UBERON:0002349 | denotes | ts with CO |
T74631 | 10352-10365 | GO:0007596 | denotes | elative role |
T1706 | 10492-10497 | CHEBI:36044;CHEBI:36044 | denotes | or th |
T69753 | 10499-10514 | CHEBI:50858;CHEBI:50858 | denotes | effect of syste |
T40512 | 10552-10560 | SP_7 | denotes | common |
T95131 | 10768-10775 | UBERON:0000948 | denotes | 5% of t |
T55330 | 10837-10845 | SP_7 | denotes | t myocar |
T43403 | 10869-10879 | SP_7 | denotes | . No study |
T97008 | 10885-10890 | PR:000013883 | denotes | escri |
T90587 | 11118-11126 | SP_7 | denotes | also not |
T23923 | 11438-11446 | SP_7 | denotes | in COVI |
T59830 | 11511-11526 | UBERON:0002037 | denotes | nese patients w |
T91364 | 11709-11724 | UBERON:0002037 | denotes | . The type of a |
T92815 | 11811-11826 | UBERON:0002037 | denotes | ged only a few |
T25744 | 11954-11958 | CL:0000037 | denotes | nt m |
T92830 | 12168-12176 | SP_7 | denotes | d to hav |
T44699 | 12872-12877 | UBERON:0000948 | denotes | tant |
T13321 | 12902-12909 | UBERON:0000948 | denotes | ation-1 |
T1958 | 12968-12972 | GO:0016265 | denotes | our |
T10093 | 13047-13053 | GO:0016265 | denotes | heathc |
T26141 | 13217-13231 | UBERON:0004535 | denotes | of the person |
T57516 | 13250-13258 | SP_7 | denotes | ment in |
T16826 | 13271-13282 | UBERON:0002349 | denotes | th the exis |
T31833 | 13296-13306 | UBERON:0002349 | denotes | guidelines |
T58582 | 13365-13373 | SP_7 | denotes | ealing w |
T94661 | 13445-13455 | UBERON:0002349 | denotes | and/or acu |
T87705 | 13482-13489 | UBERON:0000948 | denotes | e proto |
T48656 | 13618-13625 | UBERON:0000948 | denotes | ll-rehe |
T7641 | 13765-13772 | UBERON:0000948 | denotes | to mini |
T19884 | 13982-13989 | UBERON:0000948 | denotes | minimiz |
T28710 | 14081-14086 | GO:0016265 | denotes | (e.g. |
T28698 | 14202-14209 | UBERON:0000948 | denotes | agnosti |
T59720 | 14304-14312 | SP_7 | denotes | and woul |
T39589 | 14636-14643 | UBERON:0000948 | denotes | ctually |
T43336 | 14663-14670 | UBERON:0000948 | denotes | the ma |
T74507 | 14698-14706 | SP_7 | denotes | h COVID- |
T87124 | 14800-14808 | UBERON:0001621 | denotes | use of e |
T70670 | 14810-14820 | UBERON:0002349 | denotes | ocardiogra |
T13529 | 14835-14840 | NCBITaxon:10239 | denotes | tient |
T86273 | 15015-15019 | GO:0016265 | denotes | ith |
T62094 | 15027-15031 | SP_10 | denotes | nt e |
T86471 | 15051-15055 | SP_10 | denotes | infa |
T29868 | 15090-15095 | NCBITaxon:10239 | denotes | rega |
T44693 | 15147-15152 | SP_6;NCBITaxon:9606 | denotes | ensin |
T30153 | 15153-15158 | UBERON:0000948 | denotes | recep |
T84285 | 15198-15208 | UBERON:0002349 | denotes | VID-19 pan |
T53976 | 15223-15228 | NCBITaxon:10239 | denotes | ents |
T87440 | 15291-15301 | UBERON:0002349 | denotes | cardiomyoc |
T16635 | 15316-15324 | SP_7 | denotes | e SARS-C |
T1147 | 15380-15396 | UBERON:0002084 | denotes | is a potentiall |
T55144 | 15426-15442 | UBERON:0002084 | denotes | COVID-19 or dev |
T79081 | 15547-15552 | UBERON:0000948 | denotes | o dat |
T98834 | 15564-15572 | SP_7 | denotes | mental o |
T81730 | 15587-15592 | UBERON:0000948 | denotes | have |
T81536 | 15654-15658 | GO:0016265 | denotes | s of |
T85605 | 15801-15809 | SP_7 | denotes | lly-indi |
T35536 | 15887-15895 | SP_7 | denotes | Clinicia |
T14057 | 16149-16157 | SP_7 | denotes | to be c |
T37740 | 16312-16320 | CHEBI:33695;CHEBI:33695;SO:0000673 | denotes | c option |
T78714 | 16367-16371 | SP_10 | denotes | se d |
T37413 | 16383-16391 | SP_10 | denotes | wn to pr |
T33567 | 16435-16445 | SP_7 | denotes | ercised wh |
T76508 | 16506-16510 | SP_10 | denotes | d an |
T48944 | 16550-16554 | CHEBI:18059;CHEBI:18059;GO:0006629 | denotes | oroq |
T57411 | 16555-16563 | GO:0006629 | denotes | ine alon |
T94539 | 16636-16643 | CHEBI:17234;CHEBI:17234;GO:0006006 | denotes | in pati |
T59989 | 16644-16652 | GO:0006006 | denotes | nts with |
T23787 | 16741-16758 | UBERON:0000065 | denotes | ng QT interval. |
T81322 | 16851-16859 | SP_7 | denotes | station |
T33054 | 17075-17083 | SP_7 | denotes | ering th |
T25561 | 17183-17191 | SP_7 | denotes | is ther |
T36067 | 9236-9244 | SP_7 | denotes | high-sen |
T8537 | 9534-9542 | SP_7 | denotes | forement |
T40400 | 9603-9610 | UBERON:0000948 | denotes | cidence |
T31575 | 9696-9704 | SP_7 | denotes | ad a def |
T82368 | 9994-10004 | GO:0007567 | denotes | aving seve |
T24251 | 10011-10018 | UBERON:0000948 | denotes | l illne |
T24920 | 10085-10093 | SP_7 | denotes | ntrast, |
T47609 | 10229-10236 | UBERON:0000948 | denotes | mechan |
T90774 | 10548-10558 | UBERON:0000948 | denotes | most commo |
T51367 | 10619-10626 | UBERON:0000948 | denotes | autopsy |
T20059 | 10845-10853 | SP_7 | denotes | dial inj |
T82666 | 11105-11117 | GO:0042730 | denotes | c shock have |
T97480 | 11135-11143 | SP_7 | denotes | cribed. |
T23223 | 11184-11194 | UBERON:0002349 | denotes | of heart |
T84766 | 11261-11271 | CHEBI:35222;CHEBI:35222 | denotes | of the pa |
T62908 | 11295-11312 | CHEBI:48561;CHEBI:48561 | denotes | died and in 12% o |
T65791 | 11338-11346 | SP_7 | denotes | scharged |
T61160 | 11384-11394 | GO:0010467 | denotes | s Both tac |
T42698 | 11398-11402 | G_3;PG_10;PR:000003622 | denotes | and |
T8716 | 11414-11421 | UBERON:0000479 | denotes | hmias a |
T34153 | 11436-11450 | CL:0000746 | denotes | ur in COVID-19 |
T6986 | 11463-11473 | SP_7 | denotes | cribing cl |
T91871 | 11483-11487 | G_3;PG_10;PR:000003622 | denotes | file |
T13099 | 11507-11514 | SP_6;NCBITaxon:9606 | denotes | Chines |
T51665 | 11573-11581 | SP_7 | denotes | hmia [8] |
T10783 | 12011-12019 | SP_7 | denotes | SARS, c |
T27416 | 12171-12176 | NCBITaxon:10239 | denotes | o hav |
T34190 | 12213-12218 | CHEBI:67079;CHEBI:67079 | denotes | t 12- |
T90459 | 12218-12228 | NCBITaxon:11632 | denotes | years foll |
T6997 | 12229-12234 | CHEBI:23888;CHEBI:23888 | denotes | w-up; |
T89731 | 12270-12277 | UBERON:0000948 | denotes | % and a |
T12959 | 12278-12283 | CHEBI:23888;CHEBI:23888 | denotes | tered |
T37980 | 12370-12381 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | ecovering f |
T83335 | 12382-12401 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | om other respirator |
T32885 | 12406-12418 | CHEBI:2948;CHEBI:2948 | denotes | ct infection |
T65115 | 12519-12524 | CHEBI:23888;CHEBI:23888 | denotes | porta |
T66265 | 12614-12620 | CHEBI:23888;CHEBI:23888 | denotes | rom fu |
T68492 | 12678-12689 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | ment princi |
T72351 | 12690-12708 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | les for patients p |
T96108 | 12804-12811 | UBERON:0002107 | denotes | r any o |
T69138 | 12815-12820 | UBERON:0002113 | denotes | pati |
T30274 | 12864-12868 | CHEBI:23888;CHEBI:23888 | denotes | ew i |
T302 | 13090-13098 | SP_7 | denotes | COVID-19 |
T303 | 13393-13401 | SP_7 | denotes | COVID-19 |
T304 | 13458-13465 | UBERON:0000948 | denotes | cardiac |
T305 | 13552-13560 | SP_7 | denotes | COVID-19 |
T306 | 13850-13860 | GO:0007567 | denotes | delivering |
T307 | 13867-13874 | UBERON:0000948 | denotes | cardiac |
T308 | 13941-13949 | SP_7 | denotes | COVID-19 |
T309 | 14087-14094 | UBERON:0000948 | denotes | cardiac |
T310 | 14406-14416 | UBERON:0000948 | denotes | Cardiology |
T311 | 14477-14484 | UBERON:0000948 | denotes | cardiac |
T312 | 14700-14708 | SP_7 | denotes | COVID-19 |
T313 | 14963-14975 | GO:0042730 | denotes | fibrinolysis |
T314 | 14993-15001 | SP_7 | denotes | COVID-19 |
T315 | 15040-15050 | UBERON:0002349 | denotes | myocardial |
T316 | 15119-15129 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T317 | 15153-15170 | CHEBI:48561;CHEBI:48561 | denotes | receptor blockers |
T318 | 15196-15204 | SP_7 | denotes | COVID-19 |
T319 | 15239-15249 | GO:0010467 | denotes | expression |
T320 | 15253-15257 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T321 | 15269-15276 | UBERON:0000479 | denotes | tissues |
T322 | 15291-15305 | CL:0000746 | denotes | cardiomyocytes |
T323 | 15318-15328 | SP_7 | denotes | SARS-CoV-2 |
T324 | 15338-15342 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T325 | 15362-15367 | SP_6;NCBITaxon:9606 | denotes | human |
T326 | 15427-15435 | SP_7 | denotes | COVID-19 |
T327 | 15866-15874 | SP_7 | denotes | COVID-19 |
T328 | 16028-16033 | NCBITaxon:10239 | denotes | viral |
T329 | 16067-16072 | CHEBI:67079;CHEBI:67079 | denotes | anti- |
T330 | 16072-16082 | NCBITaxon:11632 | denotes | retroviral |
T331 | 16083-16088 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T332 | 16124-16131 | UBERON:0000948 | denotes | cardiac |
T333 | 16132-16137 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T334 | 16222-16233 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T335 | 16234-16252 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T336 | 16257-16269 | CHEBI:2948;CHEBI:2948 | denotes | azathioprine |
T337 | 16370-16375 | CHEBI:23888;CHEBI:23888 | denotes | drugs |
T338 | 16466-16472 | CHEBI:23888;CHEBI:23888 | denotes | agents |
T339 | 16528-16539 | CHEBI:3638;DG_10;CHEBI:3638 | denotes | chloroquine |
T340 | 16540-16558 | CHEBI:5801;DG_20;CHEBI:5801 | denotes | hydroxychloroquine |
T341 | 16653-16660 | UBERON:0002107 | denotes | hepatic |
T342 | 16664-16669 | UBERON:0002113 | denotes | renal |
T343 | 16713-16717 | CHEBI:23888;CHEBI:23888 | denotes | drug |
T4488 | 16800-16811 | UBERON:0001004 | denotes | respiratory |
T59575 | 16862-16870 | SP_7 | denotes | COVID-19 |
T12110 | 16949-16957 | SP_7 | denotes | COVID-19 |
T51515 | 17015-17022 | UBERON:0000948 | denotes | cardiac |
T28958 | 17149-17157 | SP_7 | denotes | COVID-19 |
T29729 | 17241-17249 | SP_7 | denotes | COVID-19 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32247212-28831119-25241177 | 2470-2472 | 28831119 | denotes | 12 |
32247212-31986264-25241178 | 5503-5504 | 31986264 | denotes | 6 |
32247212-31986264-25241179 | 6834-6835 | 31986264 | denotes | 6 |
32247212-31986264-25241180 | 9955-9956 | 31986264 | denotes | 6 |
32247212-19453650-25241181 | 10704-10706 | 19453650 | denotes | 11 |
32247212-28831119-25241182 | 12311-12313 | 28831119 | denotes | 12 |
32247212-15897343-25241183 | 15307-15309 | 15897343 | denotes | 17 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
90 | 974-992 | Gene | denotes | cardiac troponin I | Gene:7137 |
91 | 2274-2282 | Species | denotes | patients | Tax:9606 |
92 | 919-933 | Disease | denotes | cardiac injury | MESH:D006331 |
93 | 1085-1117 | Disease | denotes | cardiovascular abnormality • Can | MESH:D002318 |
94 | 1170-1210 | Disease | denotes | myocardial injury •Systemic inflammation | MESH:D009202 |
95 | 1423-1435 | Disease | denotes | inflammation | MESH:D007249 |
96 | 1489-1512 | Disease | denotes | coronary artery disease | MESH:D003324 |
97 | 1513-1550 | Disease | denotes | Left ventricular systolic dysfunction | MESH:D018487 |
98 | 1585-1607 | Disease | denotes | myocardial dysfunction | MESH:D009202 |
99 | 1642-1693 | Disease | denotes | left ventricular systolic dysfunction Heart failure | MESH:D006333 |
100 | 1734-1738 | Disease | denotes | died | MESH:D003643 |
101 | 1814-1836 | Disease | denotes | myocardial dysfunction | MESH:D009202 |
102 | 1871-1913 | Disease | denotes | heart failure • Increased metabolic demand | MESH:D008659 |
103 | 1990-2014 | Disease | denotes | heart failure Arrhythmia | MESH:D001145 |
104 | 2082-2117 | Disease | denotes | tachyarrhythmia and bradyarrhythmia | MESH:D001919 |
105 | 2239-2263 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
106 | 2389-2434 | Disease | denotes | abnormalities of lipid and glucose metabolism | MESH:D044882 |
107 | 2442-2468 | Disease | denotes | cardiovascular homeostasis | MESH:D002318 |
109 | 855-879 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
112 | 2482-2496 | Disease | denotes | cardiac injury | MESH:D006331 |
113 | 2679-2703 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
121 | 33-50 | Species | denotes | novel coronavirus | Tax:2697049 |
122 | 72-119 | Species | denotes | Severe Acute Respiratory Syndrome-Coronavirus-2 | Tax:2697049 |
123 | 121-131 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
124 | 468-492 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
125 | 494-504 | Disease | denotes | COVID-2019 | MESH:C000657245 |
126 | 631-640 | Disease | denotes | infection | MESH:D007239 |
127 | 742-748 | Disease | denotes | deaths | MESH:D003643 |
139 | 2749-2764 | Disease | denotes | flulike illness | MESH:D002908 |
140 | 2787-2822 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
141 | 2836-2845 | Disease | denotes | pneumonia | MESH:D011014 |
142 | 2889-2897 | Disease | denotes | COVID-19 | MESH:C000657245 |
143 | 2928-2955 | Disease | denotes | respiratory tract infection | MESH:D012141 |
144 | 2970-2992 | Disease | denotes | cardiovascular disease | MESH:D002318 |
145 | 2994-2997 | Disease | denotes | CVD | MESH:D002318 |
146 | 3044-3052 | Disease | denotes | COVID-19 | MESH:C000657245 |
147 | 3063-3071 | Disease | denotes | COVID-19 | MESH:C000657245 |
148 | 3094-3097 | Disease | denotes | CVD | MESH:D002318 |
149 | 3127-3148 | Disease | denotes | cardiac complications | MESH:D005117 |
159 | 3225-3233 | Species | denotes | patients | Tax:9606 |
160 | 3357-3365 | Species | denotes | patients | Tax:9606 |
161 | 3600-3611 | Species | denotes | coronavirus | Tax:11118 |
162 | 3250-3258 | Disease | denotes | COVID-19 | MESH:C000657245 |
163 | 3287-3290 | Disease | denotes | CVD | MESH:D002318 |
164 | 3305-3326 | Disease | denotes | cardiac complications | MESH:D005117 |
165 | 3559-3567 | Disease | denotes | COVID-19 | MESH:C000657245 |
166 | 3639-3671 | Disease | denotes | Middle-East Respiratory Syndrome | MESH:D018352 |
167 | 3673-3677 | Disease | denotes | MERS | MESH:D018352 |
175 | 3954-3965 | Species | denotes | coronavirus | Tax:11118 |
176 | 3906-3914 | Disease | denotes | COVID-19 | MESH:C000657245 |
177 | 3939-3947 | Disease | denotes | COVID-19 | MESH:C000657245 |
178 | 4027-4037 | Disease | denotes | arrhythmia | MESH:D001145 |
179 | 4041-4062 | Disease | denotes | myocardial infarction | MESH:D009203 |
180 | 4081-4094 | Disease | denotes | heart failure | MESH:D006333 |
181 | 4159-4163 | Disease | denotes | MERS | MESH:D018352 |
192 | 4790-4821 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
193 | 4823-4827 | Gene | denotes | ACE2 | Gene:59272 |
194 | 4908-4912 | Gene | denotes | ACE2 | Gene:59272 |
195 | 5065-5069 | Gene | denotes | ACE2 | Gene:59272 |
196 | 5098-5102 | Gene | denotes | ACE2 | Gene:59272 |
197 | 4746-4756 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
198 | 4764-4769 | Species | denotes | human | Tax:9606 |
199 | 5051-5061 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
200 | 4727-4744 | Disease | denotes | myocardial injury | MESH:D009202 |
201 | 5155-5166 | Disease | denotes | lung injury | MESH:D055370 |
206 | 5461-5469 | Species | denotes | patients | Tax:9606 |
207 | 5187-5199 | Disease | denotes | inflammation | MESH:D007249 |
208 | 5222-5230 | Disease | denotes | COVID-19 | MESH:C000657245 |
209 | 5491-5499 | Disease | denotes | COVID-19 | MESH:C000657245 |
215 | 5702-5708 | Chemical | denotes | oxygen | MESH:D010100 |
216 | 5604-5622 | Disease | denotes | systemic infection | MESH:D007239 |
217 | 5636-5643 | Disease | denotes | hypoxia | MESH:D000860 |
218 | 5660-5679 | Disease | denotes | respiratory illness | MESH:D012140 |
219 | 5754-5771 | Disease | denotes | myocardial injury | MESH:D009202 |
224 | 5796-5815 | Disease | denotes | coronary thrombosis | MESH:D003328 |
225 | 5826-5838 | Disease | denotes | inflammation | MESH:D007249 |
226 | 5960-5981 | Disease | denotes | myocardial infarction | MESH:D009203 |
227 | 6024-6036 | Disease | denotes | inflammation | MESH:D007249 |
229 | 6186-6194 | Disease | denotes | COVID-19 | MESH:C000657245 |
241 | 6370-6373 | Gene | denotes | esp | Gene:148713 |
242 | 6378-6386 | Species | denotes | patients | Tax:9606 |
243 | 6502-6512 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
244 | 6536-6547 | Chemical | denotes | aldosterone | MESH:D000450 |
245 | 6324-6340 | Disease | denotes | systemic illness | MESH:D002908 |
246 | 6357-6368 | Disease | denotes | arrhythmias | MESH:D001145 |
247 | 6403-6419 | Disease | denotes | cardiac disorder | MESH:D006331 |
248 | 6455-6466 | Disease | denotes | hypokalemia | MESH:D007008 |
249 | 6470-6478 | Disease | denotes | COVID-19 | MESH:C000657245 |
250 | 6560-6571 | Disease | denotes | Hypokalemia | MESH:D007008 |
251 | 6607-6623 | Disease | denotes | tachyarrhythmias | MESH:D013610 |
262 | 4216-4226 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
263 | 4262-4278 | Species | denotes | beta-coronavirus | Tax:694002 |
264 | 4303-4321 | Species | denotes | beta-coronaviruses | Tax:694002 |
265 | 4341-4346 | Species | denotes | human | Tax:9606 |
266 | 4563-4573 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
267 | 4347-4357 | Disease | denotes | infections | MESH:D007239 |
268 | 4389-4405 | Disease | denotes | flulike symptoms | MESH:D051271 |
269 | 4478-4482 | Disease | denotes | MERS | MESH:D018352 |
270 | 4499-4507 | Disease | denotes | COVID-19 | MESH:C000657245 |
271 | 4701-4709 | Disease | denotes | COVID-19 | MESH:C000657245 |
293 | 6672-6680 | Species | denotes | patients | Tax:9606 |
294 | 6905-6913 | Species | denotes | patients | Tax:9606 |
295 | 7060-7068 | Species | denotes | patients | Tax:9606 |
296 | 7946-7954 | Species | denotes | patients | Tax:9606 |
297 | 6699-6702 | Disease | denotes | CVD | MESH:D002318 |
298 | 6754-6762 | Disease | denotes | COVID-19 | MESH:C000657245 |
299 | 6982-6991 | Disease | denotes | infection | MESH:D007239 |
300 | 7074-7082 | Disease | denotes | COVID-19 | MESH:C000657245 |
301 | 7128-7136 | Disease | denotes | diabetes | MESH:D003920 |
302 | 7138-7168 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
303 | 7173-7185 | Disease | denotes | hypertension | MESH:D006973 |
304 | 7231-7239 | Disease | denotes | diabetes | MESH:D003920 |
305 | 7244-7256 | Disease | denotes | hypertension | MESH:D006973 |
306 | 7337-7367 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
307 | 7427-7435 | Disease | denotes | diabetes | MESH:D003920 |
308 | 7437-7467 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
309 | 7472-7484 | Disease | denotes | hypertension | MESH:D006973 |
310 | 7803-7811 | Disease | denotes | COVID-19 | MESH:C000657245 |
311 | 7960-7972 | Disease | denotes | hypertension | MESH:D006973 |
312 | 7974-7982 | Disease | denotes | diabetes | MESH:D003920 |
313 | 7987-7990 | Disease | denotes | CVD | MESH:D002318 |
323 | 8320-8328 | Species | denotes | patients | Tax:9606 |
324 | 8571-8579 | Species | denotes | patients | Tax:9606 |
325 | 8590-8598 | Species | denotes | patients | Tax:9606 |
326 | 8766-8774 | Species | denotes | patients | Tax:9606 |
327 | 8462-8470 | Disease | denotes | diabetes | MESH:D003920 |
328 | 8492-8516 | Disease | denotes | congestive heart failure | MESH:D006333 |
329 | 8533-8552 | Disease | denotes | cardiac dysfunction | MESH:D006331 |
330 | 8599-8603 | Disease | denotes | died | MESH:D003643 |
331 | 8679-8685 | Disease | denotes | deaths | MESH:D003643 |
333 | 8884-8892 | Disease | denotes | COVID-19 | MESH:C000657245 |
335 | 8907-8924 | Disease | denotes | myocardial injury | MESH:D009202 |
341 | 9253-9271 | Gene | denotes | cardiac troponin I | Gene:7137 |
342 | 9273-9277 | Gene | denotes | cTnI | Gene:7137 |
343 | 8931-8948 | Disease | denotes | myocardial injury | MESH:D009202 |
344 | 8999-9007 | Disease | denotes | COVID-19 | MESH:C000657245 |
345 | 9079-9096 | Disease | denotes | myocardial injury | MESH:D009202 |
357 | 9518-9522 | Gene | denotes | cTnI | Gene:7137 |
358 | 9779-9783 | Gene | denotes | cTnI | Gene:7137 |
359 | 9678-9686 | Species | denotes | patients | Tax:9606 |
360 | 9929-9937 | Species | denotes | patients | Tax:9606 |
361 | 9965-9973 | Species | denotes | patients | Tax:9606 |
362 | 10161-10169 | Species | denotes | patients | Tax:9606 |
363 | 9399-9413 | Disease | denotes | cardiac injury | MESH:D006331 |
364 | 9620-9634 | Disease | denotes | cardiac injury | MESH:D006331 |
365 | 9719-9724 | Disease | denotes | death | MESH:D003643 |
366 | 9841-9855 | Disease | denotes | cardiac injury | MESH:D006331 |
367 | 9943-9951 | Disease | denotes | COVID-19 | MESH:C000657245 |
378 | 10323-10331 | Species | denotes | patients | Tax:9606 |
379 | 10636-10644 | Species | denotes | patients | Tax:9606 |
380 | 10788-10793 | Species | denotes | human | Tax:9606 |
381 | 10275-10298 | Disease | denotes | cardiac injury and rise | MESH:D006331 |
382 | 10337-10345 | Disease | denotes | COVID-19 | MESH:C000657245 |
383 | 10449-10466 | Disease | denotes | myocardial injury | MESH:D009202 |
384 | 10480-10491 | Disease | denotes | myocarditis | MESH:D009205 |
385 | 10518-10530 | Disease | denotes | inflammation | MESH:D007249 |
386 | 10653-10657 | Disease | denotes | died | MESH:D003643 |
387 | 10839-10856 | Disease | denotes | myocardial injury | MESH:D009202 |
400 | 11214-11222 | Species | denotes | patients | Tax:9606 |
401 | 11269-11277 | Species | denotes | patients | Tax:9606 |
402 | 11318-11326 | Species | denotes | patients | Tax:9606 |
403 | 10932-10953 | Disease | denotes | myocardial infarction | MESH:D009203 |
404 | 10957-10965 | Disease | denotes | COVID-19 | MESH:C000657245 |
405 | 11021-11058 | Disease | denotes | left ventricular systolic dysfunction | MESH:D018487 |
406 | 11066-11090 | Disease | denotes | left ventricular failure | MESH:D018487 |
407 | 11095-11112 | Disease | denotes | cardiogenic shock | MESH:D012770 |
408 | 11188-11201 | Disease | denotes | heart failure | MESH:D006333 |
409 | 11205-11213 | Disease | denotes | COVID-19 | MESH:C000657245 |
410 | 11228-11241 | Disease | denotes | Heart failure | MESH:D006333 |
411 | 11295-11299 | Disease | denotes | died | MESH:D003643 |
413 | 11374-11385 | Disease | denotes | Arrhythmias | MESH:D001145 |
420 | 11516-11524 | Species | denotes | patients | Tax:9606 |
421 | 11402-11419 | Disease | denotes | brady-arrhythmias | MESH:D001145 |
422 | 11442-11450 | Disease | denotes | COVID-19 | MESH:C000657245 |
423 | 11530-11538 | Disease | denotes | COVID-19 | MESH:C000657245 |
424 | 11567-11577 | Disease | denotes | arrhythmia | MESH:D001145 |
425 | 11723-11733 | Disease | denotes | arrhythmia | MESH:D001145 |
439 | 11893-11901 | Species | denotes | patients | Tax:9606 |
440 | 12028-12036 | Species | denotes | SARS-CoV | Tax:694009 |
441 | 12079-12089 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
442 | 12118-12126 | Species | denotes | patients | Tax:9606 |
443 | 12360-12368 | Species | denotes | patients | Tax:9606 |
444 | 12604-12612 | Species | denotes | patients | Tax:9606 |
445 | 11794-11802 | Disease | denotes | COVID-19 | MESH:C000657245 |
446 | 12178-12211 | Disease | denotes | abnormalities of lipid metabolism | MESH:D052439 |
447 | 12235-12251 | Disease | denotes | CV abnormalities | MESH:D018376 |
448 | 12276-12302 | Disease | denotes | altered glucose metabolism | MESH:D044882 |
449 | 12391-12419 | Disease | denotes | respiratory tract infections | MESH:D012141 |
450 | 12499-12507 | Disease | denotes | COVID-19 | MESH:C000657245 |
451 | 12625-12628 | Disease | denotes | CVD | MESH:D002318 |
456 | 13022-13030 | Species | denotes | patients | Tax:9606 |
457 | 13099-13107 | Species | denotes | patients | Tax:9606 |
458 | 12992-13000 | Disease | denotes | infected | MESH:D007239 |
459 | 13090-13098 | Disease | denotes | COVID-19 | MESH:C000657245 |
466 | 13402-13410 | Species | denotes | patients | Tax:9606 |
467 | 13561-13569 | Species | denotes | patients | Tax:9606 |
468 | 13671-13679 | Species | denotes | patients | Tax:9606 |
469 | 13393-13401 | Disease | denotes | COVID-19 | MESH:C000657245 |
470 | 13552-13560 | Disease | denotes | COVID-19 | MESH:C000657245 |
471 | 13941-13949 | Disease | denotes | COVID-19 | MESH:C000657245 |
477 | 14138-14146 | Species | denotes | patients | Tax:9606 |
478 | 14686-14694 | Species | denotes | patients | Tax:9606 |
479 | 14833-14841 | Species | denotes | patients | Tax:9606 |
480 | 14371-14380 | Disease | denotes | infection | MESH:D007239 |
481 | 14700-14708 | Disease | denotes | COVID-19 | MESH:C000657245 |
485 | 14979-14987 | Species | denotes | patients | Tax:9606 |
486 | 14993-15001 | Disease | denotes | COVID-19 | MESH:C000657245 |
487 | 15040-15061 | Disease | denotes | myocardial infarction | MESH:D009203 |
498 | 15115-15118 | Gene | denotes | ACE | Gene:1636 |
499 | 15253-15257 | Gene | denotes | ACE2 | Gene:59272 |
500 | 15338-15342 | Gene | denotes | ACE2 | Gene:59272 |
501 | 15318-15328 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
502 | 15362-15367 | Species | denotes | human | Tax:9606 |
503 | 15473-15481 | Species | denotes | patients | Tax:9606 |
504 | 15849-15856 | Species | denotes | patient | Tax:9606 |
505 | 15196-15204 | Disease | denotes | COVID-19 | MESH:C000657245 |
506 | 15427-15435 | Disease | denotes | COVID-19 | MESH:C000657245 |
507 | 15866-15874 | Disease | denotes | COVID-19 | MESH:C000657245 |
518 | 16631-16634 | Gene | denotes | esp | Gene:148713 |
519 | 15915-15923 | Species | denotes | patients | Tax:9606 |
520 | 16639-16647 | Species | denotes | patients | Tax:9606 |
521 | 16222-16233 | Chemical | denotes | chloroquine | MESH:D002738 |
522 | 16234-16252 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
523 | 16257-16269 | Chemical | denotes | azathioprine | MESH:D001379 |
524 | 16528-16539 | Chemical | denotes | chloroquine | MESH:D002738 |
525 | 16540-16558 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
526 | 16028-16043 | Disease | denotes | viral infection | MESH:D001102 |
527 | 16653-16681 | Disease | denotes | hepatic or renal dysfunction | MESH:D008107 |
533 | 12698-12706 | Species | denotes | patients | Tax:9606 |
534 | 12816-12823 | Species | denotes | patient | Tax:9606 |
535 | 12723-12731 | Disease | denotes | COVID-19 | MESH:C000657245 |
536 | 12786-12789 | Disease | denotes | CVD | MESH:D002318 |
537 | 12832-12840 | Disease | denotes | COVID-19 | MESH:C000657245 |
548 | 16935-16943 | Species | denotes | patients | Tax:9606 |
549 | 17372-17380 | Species | denotes | patients | Tax:9606 |
550 | 16800-16819 | Disease | denotes | respiratory illness | MESH:D012140 |
551 | 16862-16870 | Disease | denotes | COVID-19 | MESH:C000657245 |
552 | 16949-16957 | Disease | denotes | COVID-19 | MESH:C000657245 |
553 | 16990-16993 | Disease | denotes | CVD | MESH:D002318 |
554 | 17015-17034 | Disease | denotes | cardiac dysfunction | MESH:D006331 |
555 | 17141-17144 | Disease | denotes | CVD | MESH:D002318 |
556 | 17149-17157 | Disease | denotes | COVID-19 | MESH:C000657245 |
557 | 17241-17249 | Disease | denotes | COVID-19 | MESH:C000657245 |